Non-fatal MI as surrogate end point for all-cause or cardiovascular mortality
- PMID: 35031686
- DOI: 10.1038/s41569-021-00667-5
Non-fatal MI as surrogate end point for all-cause or cardiovascular mortality
Comment on
-
Assessment of Nonfatal Myocardial Infarction as a Surrogate for All-Cause and Cardiovascular Mortality in Treatment or Prevention of Coronary Artery Disease: A Meta-analysis of Randomized Clinical Trials.JAMA Intern Med. 2021 Dec 1;181(12):1575-1587. doi: 10.1001/jamainternmed.2021.5726. JAMA Intern Med. 2021. PMID: 34694318 Free PMC article. Review.
References
-
- O’Fee, K., Deych, E., Ciani, O. & Brown, D. L. Assessment of nonfatal myocardial infarction as a surrogate for all-cause and cardiovascular mortality in treatment or prevention of coronary artery disease: a meta-analysis of randomized clinical trials. JAMA Intern. Med. 181, 1575–1587 (2021). - DOI
-
- Paoletti, X. et al. Assessment of progression-free survival as a surrogate end point of overall survival in first-line treatment of ovarian cancer: a systematic review and meta-analysis. JAMA Netw. Open 3, e1918939 (2020). - DOI
-
- Thygesen, K. et al. Universal definition of myocardial infarction. Circulation 116, 2634–2653 (2007). - DOI
-
- Thygesen, K. et al. Third universal definition of myocardial infarction. Eur. Heart J. 33, 2551–2567 (2012). - DOI
-
- Thygesen, K. et al. Fourth universal definition of myocardial infarction (2018). Circulation 138, e618–e651 (2018). - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
